Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Solasta ApS
APS
Dissolved
Advertising protection
CVR 40762027
Granvej 10K, 7190
Billund
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 6 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Solasta ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
Income statement
DKK thousands
Item
2020
Revenue
0
Staff expenses
-0
EBITDA
-19
Depreciation & amort.
-0
EBIT
-19
Net financials
0
Profit before tax
-19
Tax
-0
Net profit
-19
Balance sheet
DKK thousands
Item
2020
Total assets
44
Equity
31
Long-term debt
0
Short-term debt
13
Total debt
13
Financial ratios
5-year trend
EBITDA margin
-1879500.0%
This company
15.8%
Market median
-11895670% vs market
2020
2020
Equity ratio
71.4%
This company
38.2%
Market median
+87% vs market
2020
2020
Return on equity
-60.2%
This company
18.4%
Market median
-427% vs market
2020
2020
Net profit margin
-1879500.0%
This company
8.1%
Market median
-23203804% vs market
2020
2020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2020
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
2020
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2019-08-22 – 2020-09-30
View
PDF
More on Solasta ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
